Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001199835-24-000539
Filing Date
2024-12-05
Accepted
2024-12-05 10:56:44
Documents
39
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 POINT OF CARE NANO-TECHNOLOGY, INC. 10-Q/A, AMENDMENT NO. 1 pcnt-10q.htm   iXBRL 10-Q/A 566778
2 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUN pcnt-ex31.htm EX-31.1 16498
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT pcnt-ex32.htm EX-32.1 5932
  Complete submission text file 0001199835-24-000539.txt   2025953

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcnt-20231031.xsd EX-101.SCH 17006
5 XBRL CALCULATION FILE pcnt-20231031_cal.xml EX-101.CAL 20268
6 XBRL DEFINITION FILE pcnt-20231031_def.xml EX-101.DEF 47329
7 XBRL LABEL FILE pcnt-20231031_lab.xml EX-101.LAB 119023
8 XBRL PRESENTATION FILE pcnt-20231031_pre.xml EX-101.PRE 91598
43 EXTRACTED XBRL INSTANCE DOCUMENT pcnt-10q_htm.xml XML 240091
Mailing Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889
Business Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889 732-723-7395
Point of Care Nano-Technology, Inc. (Filer) CIK: 0001504239 (see all company filings)

EIN.: 272830681 | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 000-56356 | Film No.: 241528177
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)